Hsbc Holdings PLC’s Eli Lilly & Co Position
Does Hsbc Holdings PLC own Eli Lilly & Co (LLY)? Yes — 1.87M shares worth $1.7B (+0.90% of its 13F portfolio) as of Q1 2026, down from 1.89M shares the prior filed quarter.
Position Value
$1.7B
Q1 2026
Shares
1.87M
% of Portfolio
+0.90%
Quarters Held
29
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.87M | $1.7B | +0.90% |
| Q3 2025 | 1.89M | $1.4B | +0.79% |
| Q2 2025 | 2.00M | $1.6B | +0.93% |
| Q1 2025 | 2.13M | $1.8B | +1.08% |
| Q4 2024 | 2.08M | $1.6B | +0.93% |
| Q3 2024 | 2.15M | $1.9B | +1.11% |
| Q2 2024 | 2.28M | $2.1B | +1.26% |
| Q1 2024 | 2.19M | $1.7B | +1.15% |
| Q4 2023 | 1.75M | $1.0B | +0.89% |
| Q3 2023 | 1.51M | $810M | +0.84% |
| Q2 2023 | 1.38M | $647M | +0.66% |
| Q1 2023 | 1.26M | $433M | +0.52% |
| Q4 2022 | 1.38M | $502M | +0.58% |
| Q3 2022 | 881.4K | $288M | +0.47% |
| Q2 2022 | 1.06M | $344M | +0.48% |
| Q1 2022 | 913.5K | $263M | +0.32% |
| Q4 2021 | 963.5K | $267M | +0.25% |
| Q3 2021 | 1.06M | $244M | +0.25% |
| Q2 2021 | 1.07M | $245M | +0.26% |
| Q1 2021 | 1.14M | $213M | +0.25% |
| Q4 2020 | 1.21M | $204M | +0.27% |
| Q3 2020 | 1.08M | $159M | +0.25% |
| Q2 2020 | 861.6K | $141M | +0.27% |
| Q1 2020 | 947.8K | $131M | +0.31% |
| Q4 2019 | 990.9K | $131M | +0.23% |
| Q3 2019 | 889.3K | $99M | +0.19% |
| Q2 2019 | 899.8K | $100M | +0.19% |
| Q1 2019 | 837.5K | $109M | +0.20% |
| Q4 2018 | 912.2K | $105M | +0.19% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hsbc Holdings PLC’s full portfolio or all institutional holders of LLY.